Kiran Yanamandra

2.8k citations

17 papers · 2.0k indexed · 1 hit paper · h-index 14

Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological diseases and metabolism 2
- Neuroinflammation and Neurodegeneration Mechanisms 2
Physiology top 2%
- Alzheimer's disease research and treatments 13
Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological diseases and metabolism 2
- Neuroinflammation and Neurodegeneration Mechanisms 2
Cellular and Molecular Neuroscience top 5%
Biological Psychiatry top 10%
Molecular Biology
- S100 Proteins and Annexins 4
- Prion Diseases and Protein Misfolding 3
- Machine Learning in Bioinformatics 1
- Pluripotent Stem Cells Research 1

Co-authors: Marc I. Diamond Najla Kfoury Ludmilla A. Morozova‐Roche David F. Wozniak Thomas E. Mahan Susan E. Maloney David M. Holtzman Sheng‐mei Ma
Cited by: Neurology Physiology
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Neuron (2 papers)
Partner nations: Sweden Russia United States

In The Last Decade

Kiran Yanamandra

17 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Kiran Yanamandra

Since Specialization

Citations

This map shows the geographic impact of Kiran Yanamandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiran Yanamandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiran Yanamandra more than expected).

Fields of papers citing papers by Kiran Yanamandra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiran Yanamandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiran Yanamandra. The network helps show where Kiran Yanamandra may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kiran Yanamandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kiran Yanamandra Line = papers co-authored together Kiran Yanamandra links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model iScience ·Justine D. Manos,Christina N Preiss,Nandini Venkat,Joseph A. Tamm,Peter Reinhardt,Taekyung Kwon,Jessica Wu,Allison D. Winter,Thomas R. Jahn,Kiran Yanamandra,Katherine Titterton,Eric Karran,Xavier Langlois	2021	17
2	Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer’s Disease Patients: A Pilot Study Cells ·Satoshi Muraoka,Mark P. Jedrychowski,Kiran Yanamandra,Seiko Ikezu,Steven P. Gygi,Tsuneya Ikezu	2020	96
3	Anti‐tau antibody reduces insoluble tau and decreases brain atrophy Annals of Clinical and Translational Neurology ·Kiran Yanamandra,Hong Jiang,Thomas E. Mahan,Susan E. Maloney,David F. Wozniak,Marc I. Diamond,David M. Holtzman	2015	133
4	PARKINSON'S DISEASE PROGRESSION Journal of Neuroimmunology ·Gruden,В. В. Шерстнев,Robert D. E. Sewell,Kiran Yanamandra,Ludmilla A. Morozova‐Roche,T.V. Davidova,V. G. Kucheryanu,Е. В. Бочаров,О. А. Бочарова,Vsevolod V. Poleschuk	2014	9
5	Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seedsbreakdown → Proceedings of the National Academy of Sciences ·Brandon B. Holmes,Sarah L. DeVos,Najla Kfoury,Mei Li,Rachel Lauren Jacks,Kiran Yanamandra,Mohand Ouidir Ouidja,Frances M. Brodsky,Jayne Marasa,Devika P. Bagchi,Paul T. Kotzbauer,Timothy M. Miller,Dulce Papy-García,Marc I. Diamond	2013	649
6	Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo Neuron ·Kiran Yanamandra,Najla Kfoury,Hong Jiang,Thomas E. Mahan,Sheng‐mei Ma,Susan E. Maloney,David F. Wozniak,Marc I. Diamond,David M. Holtzman	2013	430
7	Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo Neuron ·Kiran Yanamandra,Najla Kfoury,Hong Jiang,Thomas E. Mahan,Sheng‐mei Ma,Susan E. Maloney,David F. Wozniak,Marc I. Diamond,David M. Holtzman	2013	8
8	Nasal inoculation with α-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamine Behavioural Brain Research ·M. A. Gruden,Tatiana V. Davidova,Kiran Yanamandra,V. G. Kucheryanu,Ludmilla A. Morozova‐Roche,В. В. Шерстнев,Robert D. E. Sewell	2013	13
9	S100A6 Amyloid Fibril Formation Is Calcium-modulated and Enhances Superoxide Dismutase-1 (SOD1) Aggregation Journal of Biological Chemistry ·Hugo M. Botelho,Sónia S. Leal,Isabel Cardoso,Kiran Yanamandra,Ludmilla A. Morozova‐Roche,G. Fritz,Cláudio M. Gomes	2012	33
10	Formation of amyloid-like fibrillar structures and destruction of fibroblasts of the Tenon’s capsule in progressive myopia due to resistance of the pigment epithelium-derived factor to restricted proteolysis Russian Journal of Bioorganic Chemistry ·Н. И. Минкевич,Tatiana V. Rakitina,А. П. Богачук,В. В. Радченко,Е. А. Сурина,Ludmilla A. Morozova‐Roche,Kiran Yanamandra,Е. Н. Иомдина,И И Бабиченко,I. A. Коstanyan,В. М. Липкин	2012	1
11	Correlation between Protective Immunity to α-Synuclein Aggregates, Oxidative Stress and Inflammation NeuroImmunoModulation ·M. A. Gruden,Kiran Yanamandra,V. G. Kucheryanu,Olga R. Bocharova,В. В. Шерстнев,Ludmilla A. Morozova‐Roche,Robert D. E. Sewell	2012	34
12	α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients PLoS ONE ·Kiran Yanamandra,M. A. Gruden,Vida Časaitė,Rolandas Meškys,Lars Forsgren,Ludmilla A. Morozova‐Roche	2011	134
13	Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression Journal of Neuroimmunology ·M. A. Gruden,Robert D. E. Sewell,Kiran Yanamandra,T.V. Davidova,V. G. Kucheryanu,Evgeny V. Bocharov,О. А. Бочарова,Vsevolod V. Polyschuk,В. В. Шерстнев,Ludmilla A. Morozova‐Roche	2011	89
14	Lability Landscape and Protease Resistance of Human Insulin Amyloid: A New Insight into Its Molecular Properties Journal of Molecular Biology ·Mantas Mališauskas,Christoph Weise,Kiran Yanamandra,Magnus Wolf‐Watz,Ludmilla A. Morozova‐Roche	2009	18
15	Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate PLoS ONE ·Kiran Yanamandra,Oleg A. Alexeyev,Vladimir Zamotin,Vaibhav Srivastava,Andrei Shchukarev,Ann-Christin Brorsson,Gian Gaetano Tartaglia,Thomas Vogl,Rakez Kayed,Gunnar Wingsle,Jan Olsson,Christopher M. Dobson,Anders Bergh,Fredrik Elgh,Ludmilla A. Morozova‐Roche	2009	95
16	Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patients European Journal of Neurology ·K. Wilhelm,Kiran Yanamandra,M. A. Gruden,Vladimir Zamotin,Mantas Mališauskas,Vida Časaitė,Adas Darinskas,Lars Forsgren,Ludmilla A. Morozova‐Roche	2007	72
17	Lysozyme Amyloid Oligomers and Fibrils Induce Cellular Death via Different Apoptotic/Necrotic Pathways Journal of Molecular Biology ·Anna L. Gharibyan,Vladimir Zamotin,Kiran Yanamandra,Olesya S. Moskaleva,Boris A. Margulis,I. A. Коstanyan,Ludmilla A. Morozova‐Roche	2006	183

About Kiran Yanamandra

Kiran Yanamandra is a scholar working on Physiology, Neurology and Neurology, having authored 17 papers that have together received 2.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (13 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), S100 Proteins and Annexins (4 papers), Prion Diseases and Protein Misfolding (3 papers), Neurological diseases and metabolism (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Machine Learning in Bioinformatics (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Neurology (613 citations), Physiology (1.2k citations) and Neurology (575 citations). Kiran Yanamandra has collaborated with scholars based in Sweden, Russia and United States. Frequent co-authors include Marc I. Diamond, Najla Kfoury, Ludmilla A. Morozova‐Roche, David F. Wozniak, Thomas E. Mahan, Susan E. Maloney, David M. Holtzman, Sheng‐mei Ma, Hong Jiang and Dulce Papy-García. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact